What is ABEO's P/E ratio?

Abeona Therapeutics Inc (ABEO) currently trades at a P/E ratio of 3.35.

Abeona Therapeutics Inc reports a Return on Equity (ROE) of 45.63%.

What is ABEO's dividend yield?

Abeona Therapeutics Inc offers a dividend yield of 0.00%.

What is ABEO's Quality Score?

Our AI rates ABEO's overall financial quality at 62 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy ABEO?

Our AI Timing Score for ABEO is 89 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does ABEO belong to?

Abeona Therapeutics Inc is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange

Abeona Therapeutics Inc (ABEO) Stock Price

Stock Check Daily update data at 8:30 AM
(Price: 2026-08-04 | FS: 2026-03-31)

ABEO AI Analysis Summary

Our AI summary for ABEO: Abeona Therapeutics Inc (NASDAQ), Healthcare >> Biotechnology sector. The stock currently trades at a P/E of 3.35, ROE of 45.63%, a dividend yield of 0.00%. Its financial Quality Score stands at 62/100 — mid-range fundamentals relative to the market. The AI Timing Score is 89/100 — multiple technical signals currently support price momentum. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.

ABEO

Abeona Therapeutics Inc

US:NASDAQ STOCK Healthcare >> Biotechnology News 99

USD 6.82

0.43 (6.73%) Day Change

Watchlist Portfolio Compare Chart

3.35

P/E

0.13

D/E

45.6%

ROE

33.3%

ROA

0.00%

Div Yield

ABEONA THERAPEUTICS INC
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 6.82 Price 0.43 (6.73%) Day Change	NEWS SCORE: 99

ABEO, the overall quality is ok ( Quality = 62) and the timing to buy is ...(Sign In to See)...

Loading chart...

62 QUALITY

Signal: NEUTRAL

Signal Description: Company financial health is OK

Reason: Acceleration of ROE growth rate is below our criteria.
Historical ROE is relatively low
Acceleration of ROA growth rate is below our criteria.
Acceleration of net profit margin growth rate is below our criteria
Historical net profit margin is relatively low.

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Momentum indicators aligned on the daily timeframe

Unlock timing signals and detailed reasons

In details, quality factors are ok , financial health is not good , and ability to make profit is ok , ...

Quality Factors

60%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	99
Magic Formula Rank by ROA	52 GOOD
Magic Formula Rank by ROE	52 GOOD
Magic Formula Rank by ROIC	47 GREAT
Price	6.82
PBV / Sector	2.51 / 44,022.72
Earning Per Share	1.24

PE / Sector	3.35 / 19.17 GREAT
PEG or PE/Growth / Sector	N/A / 1.24
Average 1M Daily Value	8.29 M
Average 1W Daily Value	6.77 M

Timing Factors

57%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

45%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

Ability to Make Profit

60%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	454.86 / 98.24 GREAT
NPM Average (%) / Sector	-669.41 / -1,697.63
NPM Change Average (%) / Sector	N/A / 5,097.97
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	33.32 / 185,260.96 GREAT
ROA Average (%) / Sector	-27.85 / 36,684.70
ROA Change Average (%) / Sector	-36.64 / 422,221.66
ROE (%) / Sector	45.63 / 243,762.23 GREAT
ROE Average (%) / Sector	-113.65 / 48,758.47
ROE Change Average (%) / Sector	-10.71 / 424,968.10
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

Return to Investors

Dividend (%) / Sector	N/A / 0.04
Dividend Average (%) / Sector	N/A / 17.04
Dividend Change Average (%) / Sector	N/A / -0.49

Registration Details

Analyze Date	2026-08-05 07:59:46
Symbol	ABEO
Name	ABEONA THERAPEUTICS INC
Sector	Healthcare >> Biotechnology
Market	NASDAQ
Listed Shares	57.00 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	364.20 / 9,586.08

News, Concensus, ...

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 6555 Carnegie Avenue, Cleveland, OH, United States, 44103

Phone: 646 813 4701

Website: https://www.abeonatherapeutics.com

Employees: 226

Sector: Healthcare >> Biotechnology

Description: Abeona Therapeutics Inc., a commercial-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases in the United States. It develops ZEVASKYN, an autologous, cell-based gene therapy for the treatment of patients with recessive dystrophic epidermolysis bullosa. The company also develops ABO-503 to treat X-linked retinoschisis; ABO-504 for the treatment of stargardt disease; and ABO-505 to treat autosomal dominant optic atrophy. In addition, it is developing AAV-based gene therapy through its AIM vector platform programs. The company was formerly known as PlasmaTech Biopharmaceuticals, Inc. and changed its name to Abeona Therapeutics Inc. in June 2015. Abeona Therapeutics Inc. was founded in 1974 and is headquartered in Cleveland, Ohio.